COMPANY

Plurexa

HQ: Seattle, WA source · plurexa.com ↗ · West Coast

Keywords: organoids

Location: Seattle, WA · source · Oct 14, 2026

Profile checked Oct 10, 2026

NIH awards 3

Annual award amounts. Total $1.9M.

Aug 20, 2026 NIH award 5R42DK136452-03 FY2026: $770,372 awarded for that fiscal year; activity R42 (STTR); PI FREEDMAN, BENJAMIN SOLOMON; recipient as written: PLUREXA LLC, Seattle, WA. Targeting Myosin to Treat Polycystic Kidney source ↗
Sep 15, 2025 NIH award 2R42DK136452-02A1 FY2025: $839,264 awarded for that fiscal year; activity R42 (STTR); PI FREEDMAN, BENJAMIN SOLOMON; recipient as written: PLUREXA LLC, Seattle, WA. Targeting Myosin to Treat Polycystic Kidn source ↗
Apr 12, 2023 NIH award 1R41DK136452-01 FY2023: $298,326 awarded for that fiscal year; activity R41 (STTR); PI FU, HONGXIA; recipient as written: PLUREXA LLC, Seattle, WA. Targeting Myosin to Treat Polycystic Kidney Disease source ↗

NIH award NIH awarded $770K (STTR Phase II 5R42DK136452-03, continuation, notice Aug 20, 2026). NIH RePORTER 5R42DK136452-03 (Aug 20, 2026)
Evidence (1 event)
- Aug 20, 2026 · NIH RePORTER 5R42DK136452-03
  Organization: PLUREXA LLC; City/State: Seattle, WA; Project number: 5R42DK136452-03; Activity code: R42; Fiscal year: 2026; Award notice date: 2026-08-20; FY total cost (award amount): 770372; Administering IC: National Institute of Diabetes and Digestive and Kidney Diseases; Project title: Targeting Myosin to Treat Polycystic Kidney Disease; Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals